CURRICULUM VITAE. Miguel Goicoechea, M.D.
|
|
- Antony Kelley
- 5 years ago
- Views:
Transcription
1 CURRICULUM VITAE Miguel Goicoechea, M.D. Office: Telephone: University of California at San Diego Antiviral Research Center 150 West Washington Street, Suite 100 San Diego, CA (619) (work) (619) (mobile) Fax: (619) Citizenship: Languages: U.S.A. Bilingual: English-Spanish Education B.A. Biology. University of Southern California, Los Angeles, CA M.D., Howard University School of Medicine, Washington, D.C Intern and Resident in Internal Medicine. Mount Sinai Medical Center, Miami Beach, FL Internal Medicine Program Director: Gloria Weinberg, M.D Postdoctoral Fellow Infectious Diseases. University of California at San Diego, San Diego, CA Division Chair: Robert Schooley, M.D. Academic Positions Clinical Investigator. University of Miami School of Medicine AIDS Clinical Research Center, Miami, FL Director: Margaret Fischl, M.D Clinical Instructor. University of California at San Diego, San Diego, CA Division of Infectious Diseases Chair: Robert Schooley, M.D present Assistant Adjunct Professor of Medicine. University of California at San Diego; Division of Infectious Diseases; San Diego, CA Chair: Robert Schooley, M.D. Honors - Awards 1992 NIH Summer Research Fellowship Recipient 1999 Resident s Choice for Intern of the Year 1
2 2003 Ortho Biotech ID Fellows Scholarship Award 2004 Bristol-Myers Squibb Virology Research Program Recipient NIH AIDS Training Grant Fellowship NIH Clinical Research Loan Repayment Program Recipient Board Certification Diplomate, American Board of Internal Medicine; 2001 Diplomate, American Board of Internal Medicine Infectious Diseases; 2005 Licensures Florida (ME8061) /2005 California (A78023) present Hospital Appointments Mount Sinai Medical Center; Miami Beach, FL 2006-present University California San Diego; San Diego, CA Clinical Practice Interests 1. In-patient care of immune compromised hosts 2. HIV-infected individuals 3. HIV-Hepatitis C co-infection treatment Research Interests 1. Immune reconstitution in the context of potent antiretroviral therapy 2. Nucleoside pharmacology Editorial Experience 2008 Ad hoc reviewer for 2007 Ad hoc reviewer for Journal of Acquired Immunodeficiency Syndrome Ad hoc reviewer for Journal of Infectious Diseases Ad hoc reviewer for Journal of Antimicrobial Chemotherapy Ad hoc reviewer for Drugs of Today Ad hoc reviewer for HIV Clinical Trials Ad hoc reviewer for Therapeutics and Clinical Risk Management 2006 Ad hoc reviewer for Human Immunology Ad hoc reviewer for Expert Opinion on Pharmacotherapy Publications 1. Goicoechea M, Fierer J, Johns S. Treatment of Candidal Cholangitis with Caspofungin in a Liver Transplant Patient: Documentation of Caspofungin Biliary Excretion (Research Letter). Clinical Infectious Diseases 2004 Apr 1; 38(7):
3 2. Goicoechea M and Haubrich RH. CD4 T Cell Percentage Versus Absolute CD4 T Cell Count in Predicting HIV Disease Progression: An Old Debate Revisited (Editorial Commentary). Journal of Infectious Diseases 2005; Sept 15; 192(6): Wagner GJ, Kanouse DE, Golinelli D, Miller LG, Daar ES, Witt MD, Diamond C, Tilles JG, Kemper CA, Larsen R, Goicoechea M, Haubrich RH, and the California Collaborative Treatment Group (CCTG). Cognitive-Behavioral Intervention to Enhance Adherence to ART: A Randomized Controlled Trial (CCTG 578). AIDS 2006 Jun 12; 20(9): Goicoechea M, Best B, Seefried E, Wagner G, Capparelli E, Haubrich and the California Collaborative Treatment Group. Failure of Modified Directly Observed Therapy Combined with Therapeutic Drug Monitoring to Enhance Antiretroviral Adherence in a Patient with Major Depression (Case Report). AIDS Patient Care and STDs 2006 Apr; 20(4): Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, Landay A, and Haubrich R. Determinants of CD4+ T-cell Recovery during Suppressive Antiretroviral Therapy: Association of Immune Activation, T-cell Maturation Markers and Cellular HIV-1 DNA. Journal of Infectious Diseases 2006; Jul 1; 194(1): Goicoechea M, Best B, Capparelli E, Haubrich R and the California Collaborative Treatment Group. Concurrent Use of Efavirenz and Oxcarbazepine May Not Affect Efavirenz Plasma Concentrations (Research Letter). Clinical Infectious Diseases 2006 Jul 1; 43(1): Goicoechea M, Best B, Capparelli E, Caperna J, Ballard C, and Haubrich R. Therapeutic Ritonavir-Boosted Atazanavir Plasma Levels During Concurrent Omeprazole Use (Research Letter). AIDS 2006 Oct 24; 20(16): Goicoechea M and Best B. Efavirenz/ emtricitabine/ tenofovir disoproxil fumarate fixed-dose combination: First-line therapy for all? (Review Article). Expert Opinion on Pharmacotherapy 2007 Feb; 8(3): Goicoechea M. Human H5N1 Influenza (Correspondence). New England Journal of Medicine 2007 Mar 29; 356(13): Goicoechea M, Vidal A, Capparelli E, Rigby A, Kemper C, Diamond C, Witt MD, Haubrich R, and the California Collaborative Treatment Group (CCTG). A Computer-Based System to Aid in the Interpretation of Plasma Concentrations of Antiretroviral Agents for Therapeutic Drug Monitoring. Antiviral Therapy 2007; 12(1): Best BM, Goicoechea M, Witt M, Miller L, Daar E, Diamond C, Tilles J, Kemper C, Larsen R, Holland DT, Sun S, Wagner G, Capparelli EV, McCutchan JA, Haubrich R and the California Collaborative Treatment Group (CCTG). A Randomized Controlled Trial of Therapeutic Drug Monitoring in Treatment-Naïve and Experienced HIV-1-Infected Patients (CCTG 578). Journal of Acquired Immunodeficiency Syndrome 2007; 46:
4 12. Goicoechea M and Smith DM. Universal HIV Testing Is It Enough? (Editorial Commentary). Clinical Infectious Diseases 2007; Nov 15 (45): Goicoechea M, Liu S, Best B, Sun S, Jain S, Kemper C, Witt M, Diamond C, Haubrich R, Louie S and the CCTG 578 Team. Greater Tenofovir-Associated Renal Function Decline in Protease Inhibitor- versus Non-Nucleoside Reverse Transcriptase Inhibitors-Based Therapy. Journal of Infectious Diseases 2008; Jan 1 (197): Goicoechea M, Liu S, Best B, Sun S, Jain S, Kemper C, Witt M, Diamond C, Haubrich R, Louie S and the CCTG 578 Team. Tenofovir-associated renal function decline (Author s Response). Journal of Infectious Diseases 2008; [in press]. 15. Best B and Goicoechea M. Efavirenz: Still First-Line King? (Review Article). Expert Opinion on Pharmacotherapy 2008; [in press]. Book Chapters 1. Goicoechea M, Haubrich R. Chapter 18: Nelfinavir. In: AIDS Therapy 3rd Edition Copyright Editors: Dolin R, Masur H, Saag MS. Elsevier Science: USA. Presented Abstracts 1. Castro JG, Goicoechea M, Monroig R, Ale-Castro MG. Prior participation in clinical trials as a predictor of virologic success in patients followed in a specialized HIV clinic. (Abstract WePeB5840) 14 th International AIDS Conference; July 7-12, 2002: Barcelona, Spain. 2. Goicoechea M, Miller C, Spina C, Currier J, Kemper C, Witt M, Leedom J, Forthal D, Keiser P, McCutchan JA, Richman D, Haubrich R, and California Collaborative Treatment Group (CCTG). Quantitative CD38 Expression on CD8 T-Cells as a Predictor of CD4 T-Cell Maintenance Among Patients Failing Salvage Antiretroviral Therapy. (Abstract: 290) 11 th Conference of Retroviruses and Opportunistic Infections; February 8-11, 2004: San Francisco, USA. 3. Goicoechea M, Landay A, Miller C, Smith D, Haubrich R and the California Collaborative Treatment Group. Immune Activation Predicts Immunologic Discordance in Patients with Virologic Control During Antiretroviral Therapy (Abstract MoPeA3079). 15 th International AIDS Conference; July 11-17, 2004: Bangkok, Thailand. 4. Goicoechea M, Vidal A, Capparelli E, Rigby A, Kemper C, Larsen R, Diamond C, Witt M, Haubrich R, and California Collaborative Treatment Group. A Computer Artificial Intelligence System to Aid in the Interpretation of Plasma Lopinavir (LPV) and Efavirenz (EFV) Drug Concentrations. (Abstract: 641). 12 th Conference of Retroviruses and Opportunistic Infections; February 22-25, 2005: Boston, MA. 4
5 5. Haubrich R, Best B, Witt M, Goicoechea M, Kemper C, Larsen R, Diamond C, Heseltine P, Capparelli E, Wagner G, McCutchan JA, and the California Collaborative Treatment Group. Determinants of the Need for Therapeutic Drug Monitoring (TDM): Rates and Predictors from CCTG 578. (Abstract: 640). 12 th Conference of Retroviruses and Opportunistic Infections; February 22-25, 2005: Boston, MA. 6. Best B, Witt M, Goicoechea M, Kemper C, Larsen R, Diamond C, Capparelli E, Wagner G, McCutchan JA, Haubrich R and the California Collaborative Treatment Group. Improved Antiretroviral Exposure with Therapeutic Drug Monitoring. (Abstract: 589) 13 th Conference of Retroviruses and Opportunistic Infections; February 4-9, 2006: Denver, CO. 7. Goicoechea M, Spina C, Currier J, Kemper C, Witt M, Leedom J, Forthal D, McCutchan JA, Richman D, Haubrich R and the California Collaborative Treatment Group. CD4 T-cell Maintenance in Treatment-Experienced Patients with Viral Failure: Association of Nadir CD4 T-cell Count, Immune Activation, and Replication Capacity. (Abstract: 422). 13 th Conference of Retroviruses and Opportunistic Infections; February 4-9, 2006: Denver, CO. 8. Goicoechea M, Liu S, Best B, Sun S, Jain S, Kemper C, Witt M, Diamond C, Haubrich R, Louie S and the CCTG 578 Team. Increased Renal Impairment in Patients Receiving Tenofovir Disoproxil Fumarate (TDF) + Protease Inhibitors versus TDF + Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (Abstract: 835). 14 th Conference of Retroviruses and Opportunistic Infections; February 25-28, 2007: Los Angeles, CA. 9. Goicoechea M, Louie L, [USC lab], Jain S, Sun S, [GSK] and Haubrich R and the California Collaborative Treatment Group. Measurement Variability in Specimen Processing and Mass Spectrometric Analysis of Intracellular Carbovir Triphosphate Concentrations (Abstract: P45). 9th International Workshop on Clinical Pharmacology of HIV Therapy; April 7-9, 2008: New Orleans, LA. 5
Anumber of clinical trials have demonstrated
IMPROVING THE UTILITY OF PHENOTYPE RESISTANCE ASSAYS: NEW CUT-POINTS AND INTERPRETATION * Richard Haubrich, MD ABSTRACT The interpretation of a phenotype assay is determined by the cut-point, which defines
More informationPerspective Resistance and Replication Capacity Assays: Clinical Utility and Interpretation
Perspective Resistance and Replication Capacity Assays: Clinical Utility and Interpretation Resistance testing has emerged as an important tool for antiretroviral management. Research continues to refine
More informationCURRICULUM VITAE 1976 B.A., COLUMBIA COLLEGE, NEW YORK, NY 1980 DOCTOR OF MEDICINE, MOUNT SINAI SCHOOL OF MEDICINE, NEW YORK, NY
CURRICULUM VITAE GEORGE E. MU OZ, M.D. ARTHRITIS & OSTEOPOROSIS TREATMENT & RESEARCH CENTER, INC. 20880 WEST DIXIE HIGHWAY, SUITE 101 NORTH MIAMI BEACH, FL 33180 (305) 682-1441 FAX: (305) 682-8930 EDUCATION:
More informationCURRICULUM VITAE PERSONAL: Date of Birth: September 14, 1962
Phone: 858-616-6400 Fax: 858-616-6936 www.rmmorthopaedics.com CURRICULUM VITAE PERSONAL: Date of Birth: September 14, 1962 Place of Birth: West Islip, New York Citizenship: U.S.A. Office Address: 3444
More informationThe advent of protease inhibitors (PIs) as PROCEEDINGS CLINICAL EXPECTATIONS OF EFFICACY: PROTEASE INHIBITOR POTENCY * Benjamin Young, MD, PhD
CLINICAL EXPECTATIONS OF EFFICACY: PROTEASE INHIBITOR POTENCY * Benjamin Young, MD, PhD ABSTRACT Tremendous strides were made in reducing the morbidity and mortality associated with HIV infection with
More informationMindie H. Nguyen, MD, MAS, AGAF, FAASLD
CLINICAL OFFICES Digestive Health Liver Clinic 900 Blake Wilbur Dr MC 5355 Palo Alto, CA 94304 Tel (650) 498-7999 Fax (650) 724-9454 Liver Transplant Clinic 300 Pasteur Dr A160 Bio MC 5309 Stanford, CA
More informationDifferences in Calculated Glomerular Filtration Rates (GFR) in Efavirenz (EFV) or Tenofovir (TDF)-treated Adults in ESS40006
13th Conference on Retroviruses and Opportunistic Infections Denver, CO, USA. February 5-9, 2006 Poster Number 777 Differences in Calculated Glomerular Filtration Rates (GFR) in Efavirenz (EFV) or Tenofovir
More informationPrinciples of Antiretroviral Therapy
Principles of Antiretroviral Therapy Ten Principles of Antiretroviral Therapy Skills Building Workshop: Clinical Management of HIV Infection and Antiretroviral Therapy, 11 th ICAAP, November 21st, 2011,
More informationDistribution and Effectiveness of Antiretrovirals in the Central Nervous System
Distribution and Effectiveness of Antiretrovirals in the Central Nervous System Scott Letendre, MD Associate Professor of Medicine HIV Neurobehavioral Research Center and Antiviral Research Center University
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 30 Dec 2018 00:34:16 GMT) CTRI Number CTRI/2009/091/000652 [Registered on: 27/10/2009] - Last Modified On 11/03/2014 Post Graduate Thesis Type of Trial
More informationClinical Commissioning Policy: Use of cobicistat (Tybost ) as a booster in treatment of HIV positive adults and adolescents
Clinical Commissioning Policy: Use of cobicistat (Tybost ) as a booster in treatment of HIV positive adults and adolescents 1 Clinical Commissioning Policy: Use of cobicistat (Tybost ) as a booster in
More informationThe US Food and Drug Administration has
NEW ANTIRETROVIRAL AGENTS FOR TREATMENT-EXPERIENCED PATIENTS * Roy M. Gulick, MD, MPH ABSTRACT Antiretroviral treatment regimens currently available for the treatment of the human immunodeficiency virus
More informationHIV Treatment Evolution. Kimberly Y. Smith MD MPH Vice President and Head, Global Research and Medical Strategy Viiv Healthcare
HIV Treatment Evolution Kimberly Y. Smith MD MPH Vice President and Head, Global Research and Medical Strategy Viiv Healthcare Overview of the Evolution of Antiretroviral Therapy Early Treatment 1987
More informationContinuing Education for Pharmacy Technicians
Continuing Education for Pharmacy Technicians HIV/AIDS TREATMENT Michael Denaburg, Pharm.D. Birmingham, AL Objectives: 1. Identify drugs and drug classes currently used in the management of HIV infected
More informationDNA Genotyping in HIV Infection
Frontier AIDS Education and Training Center DNA Genotyping in HIV Infection Steven C. Johnson M.D. Director, University of Colorado HIV/AIDS Clinical Program; Professor of Medicine, Division of Infectious
More informationRevised 8/19/14 1. M.A., Statistics (2010) University of Michigan, Ann Arbor, MI
Revised 8/19/14 1 JENNIFER L. WALSH Centers for Behavioral and Preventive Medicine The Miriam Hospital Coro West, Suite 309, 164 Summit Ave Providence, RI 02906 Departments of Psychiatry and Human Behavior
More informationHIV Treatment Update. Awewura Kwara, MD, MPH&TM Associate Professor of Medicine and Infectious Diseases Brown University
HIV Treatment Update Awewura Kwara, MD, MPH&TM Associate Professor of Medicine and Infectious Diseases Brown University Outline Rationale for highly active antiretroviral therapy (HAART) When to start
More informationUNIVERSITY OF MIAMI Curriculum Vitae Standard Format. 2. Name: Jesus Alberto Gomez-(Perez)
UNIVERSITY OF MIAMI Curriculum Vitae Standard Format I. PERSONAL 2. Name: Jesus Alberto Gomez-(Perez) 6. Current Academic Rank: [i.e., Instructor, Assistant Prof, Associate Prof or Professor] Assistant
More informationThis graph displays the natural history of the HIV disease. During acute infection there is high levels of HIV RNA in plasma, and CD4 s counts
1 2 This graph displays the natural history of the HIV disease. During acute infection there is high levels of HIV RNA in plasma, and CD4 s counts decreased. This period of acute infection or serocnversion
More informationBritish HIV Association Guidelines for the Management of Hepatitis Viruses in Adults Infected with HIV 2013 Appendix 2
British HIV Association Guidelines for the Management of Hepatitis Viruses in Adults Infected with HIV 2013 Appendix 2 Systematic literature search 2.1 Questions and PICO criteria Data bases: Medline,
More informationKashif Raza. Jul Jun Govt. Zamindar Degree College, FSc. Certificate Bio, Phys, Chem Gujrat, Pakistan GRADUATE:
Kashif Raza Education and Training UNDERGRADUATE: Jul. 1989 Jun. 1991 Govt. Zamindar Degree College, FSc. Certificate Bio, Phys, Chem Gujrat, Pakistan. 1991 GRADUATE: Sep.1991- Aug. 1997 Nishtar Medical
More informationHIV associated CNS disease in the era of HAART
HIV associated CNS disease in the era of HAART CSF/CNS penetration and efficacy Acknowledgements Peter Portegies Department of Neurology, AMC Mark van der Valk Department of Internal Medicine/Infectious
More informationEdward K. Nomoto, M.D.
Page 1 of 5 Appointments CURRICULUM VITAE Edward K. Nomoto, M.D. 444 S. San Vicente Blvd, Suite 800 Los Angeles, CA 90048 (310) 423-9780 (work) Cedars-Sinai Medical Center, Spine Center Faculty, Orthopaedic
More information2 nd Line Treatment and Resistance. Dr Rohit Talwani & Dr Dave Riedel 12 th June 2012
2 nd Line Treatment and Resistance Dr Rohit Talwani & Dr Dave Riedel 12 th June 2012 Overview Basics of Resistance Treatment failure Strategies to manage treatment failure Mutation Definition: A change
More informationPHARMACOKINETICS OF ANTIRETROVIRAL AND ANTI-HCV AGENTS
8. PHARMACOKINETICS OF ANTIRETROVIRAL AND ANTI-HCV AGENTS David Burger José Moltó Table 8.1a: INFLUENCE OF FOOD ON ABSORPTION (AREA UNDER THE CURVE) OF ANTIRETROVIRAL AGENTS NUCLEOSIDE ANALOGUES NtRTI
More informationSomnuek Sungkanuparph, M.D.
HIV Drug Resistance Somnuek Sungkanuparph, M.D. Associate Professor Division of Infectious Diseases Department of Medicine Faculty of Medicine Ramathibodi Hospital Mahidol University Adjunct Professor
More informationHIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body
HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body Melissa Badowski, PharmD, BCPS, AAHIVP Clinical Assistant Professor University
More informationDaniel J Escudero, PhD
Daniel J Escudero, PhD Postdoctoral Fellow Department of Epidemiology T.H. Chan School of Public Health Tel: (617) 432-1899 (office); (551) 404-7592 (cell) Email: Escudero@hsph.harvard.edu 1. EDUCATION
More informationCURRICULUM VITAE. Ohio Wesleyan University, Delaware, OH, B.A., l968. Ohio State University, College of Medicine, Columbus, OH, MD, l973
CURRICULUM VITAE Name: Date and Place of Birth: Citizenship: Marital Status: Education: JAMES B. RECTOR, MD Jan. 31, 1946, Cincinnati, OH USA Married (Susan) Ohio Wesleyan University, Delaware, OH, B.A.,
More informationA Genetic Test to Screen for Abacavir Hypersensitivity Reactions
The Future of Pharmacogenetics in HIV Clinical Care A Genetic Test to Screen for Abacavir Hypersensitivity Reactions Evan Collins & Misty Bath CANAC/ACIIS 15 th Annual Conference Vancouver, BC April 2007
More informationHERBERT SILVERSTEIN, MD, FACS Curriculum Vitae July 2, 2008
HERBERT SILVERSTEIN, MD, FACS Curriculum Vitae July 2, 2008 BUSINESS ADDRESS: 1901 Floyd Street Sarasota, FL 34239 (941) 366-9222 FAX(941) 365-2269 E-mail: hsilverste@aol.com PERSONAL INFORMATION: SCHOOLING
More informationClinical Commissioning Policy: Use of cobicistat as a booster in treatment of HIV positive adults and adolescents
Clinical Commissioning Policy: Use of cobicistat as a booster in treatment of HIV positive adults and adolescents Reference: NHS England F03/P/b NHS England INFORMATION READER BOX Directorate Medical Commissioning
More informationCURRICULUM VITAE Daniel Nelson Fish, M.D.
CURRICULUM VITAE Daniel Nelson Fish, M.D. PERSONAL: 60 Old New Milford Road (office) Brookfield, CT 06804 203-775-6205 fax 203-775-2373 EDUCATION: Undergraduate: Bachelor of Science, 1982 Chemistry and
More informationHIV Prevention Strategies HIV Pre-exposure prophylaxis
HIV Prevention Strategies HIV Pre-exposure prophylaxis Michael Martin, MD, MPH Director HIV Research Program Thailand MOPH U.S. CDC Collaboration The findings and conclusions in this presentation are those
More informationPOST-EXPOSURE PROPHYLAXIS, PRE-EXPOSURE PROPHYLAXIS, & TREATMENT OF HIV
POST-EXPOSURE PROPHYLAXIS, PRE-EXPOSURE PROPHYLAXIS, & TREATMENT OF HIV DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none
More informationFirst line ART Rilpirivine A New NNRTI. Chris Jack Physician, Durdoc Centre ethekwini
First line ART Rilpirivine A New NNRTI Chris Jack Physician, Durdoc Centre ethekwini Overview: Rilpirivine an option for ARV Naïve patients History Current guidelines Efficacy and Safety Tolerability /
More informationCarrie A. Langner Curriculum Vitae
Carrie A. Langner Curriculum Vitae Assistant Professor Psychology & Child Development California Polytechnic State University San Luis Obispo, CA 93407-0387 (805) 756-5705 clangner@calpoly.edu Training
More informationCURRICULUM VITAE. Justin M. Lantz, PT, DPT, OCS, FAAOMPT I. BIOGRAPHICAL INFORMATION
CURRICULUM VITAE Justin M. Lantz, PT, DPT, OCS, FAAOMPT I. BIOGRAPHICAL INFORMATION PERSONAL INFORMATION: University Office Ostrow School of Dentistry of USC Division of Biokinesiology and 1540 Alcazar
More informationCURRICULUM VITAE NICOLAS ZEA, MD, RPVI. Assistant Professor of Clinical Surgery
CURRICULUM VITAE NICOLAS ZEA, MD, RPVI Title: Business Address: Business Telephone and Fax: Business email address: Citizenship: Assistant Professor of Clinical Surgery LSUHSC, Department of Surgery Section
More informationIntroduction to HIV Drug Resistance. Kevin L. Ard, MD, MPH Massachusetts General Hospital Harvard Medical School
Introduction to HIV Drug Resistance Kevin L. Ard, MD, MPH Massachusetts General Hospital Harvard Medical School Objectives 1. Describe the epidemiology of HIV drug resistance in sub-saharan Africa. 2.
More informationWhat's new in the WHO ART guidelines How did markets react?
WHO 2013 ARV Guidelines What's new in the WHO ART guidelines How did markets react? Dr. J. Perriëns Coordinator, HIV Technology and Commodities HIV department, WHO, Geneva When to start in adults Starting
More informationGuidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Visit the AIDSinfo website to access the most up-to-date guideline. Register for e-mail notification of guideline
More informationScott D. Landes Assistant Professor of Sociology Maxwell School of Citizenship & Public Affairs
Scott D. Landes Assistant Professor of Sociology Maxwell School of Citizenship & Public Affairs Aging Studies Institute 314 Lyman Hall Syracuse University Syracuse, New York 13244-1020 (315) 443-3233 sdlandes@maxwell.syr.edu
More informationEXPLORING THE IMPACT OF SEX DISCREPANCIES IN HIV TREATMENT AND CURE
EXPLORING THE IMPACT OF SEX DISCREPANCIES IN HIV TREATMENT AND CURE CECILE DELILLE LAHIRI, M.D, M.SC ASSISTANT PROFESSOR DIVISION OF INFECTIOUS DISEASES MAY 18, 2016 OUTLINE Describe discrepancy between
More informationPatients with persistently low CD4 counts on antiretroviral
Predicting HIV Care Costs Using CD4 Counts From Clinical Trials Andrew Hill, PhD; and Kelly Gebo, MD, MPH Objective: To predict the effects of a new antiretroviral agent on the costs of care in a US HIV
More informationManagement of patients with antiretroviral treatment failure: guidelines comparison
The editorial staff Management of patients with antiretroviral treatment failure: guidelines comparison A change of therapy should be considered for patients if they experience sustained rebound in viral
More informationBoard-certified periodontist with more than 10 years of clinical expertise.
11620 Wilshire Blvd. Suite 340 Los Angeles, CA 90025 Phone: 888.853.7944 Fax: 213.478.0550 info@calmedeval.com Dr. Alon Frydman, DDS, Periodontist Board-Certified in Dentistry Board-certified periodontist
More informationHorizon Scanning Technology Summary. Tenofovir disoproxil fumarate for hepatitis B. National Horizon Scanning Centre. April 2007
Horizon Scanning Technology Summary National Horizon Scanning Centre Tenofovir disoproxil fumarate for hepatitis B April 2007 This technology summary is based on information available at the time of research
More informationGSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationHIV DISEASE! Neurobehavioral! Neuromedical. Igor Grant, MD, FRCP(C) Director HIV Neurobehavioral Research Program University of California, San Diego
Igor Grant, MD, FRCP(C) Director HIV Neurobehavioral Research Program University of California, San Diego HIV DISEASE! Neuromedical Neurobehavioral! HIV Neurobehavioral Disturbances HIV Associated Neurocognitive
More informationPhil Weir-Mayta, PhD, CCC-SLP Curriculum Vitae EDUCATION EMPLOYMENT REFERRED PUBLICATIONS AND PRESENTATIONS
Phil Weir-Mayta, PhD, CCC-SLP Curriculum Vitae California State University Fullerton Phone: 714-548-5350 Communication Sciences and Disorders Fax: 657.278.3377 800 N. State College Blvd., Suite 420 Email:
More informationDavid W. Miller, M.D., L.Ac. February 2017
PERSONAL INFORMATION Name: David W. Miller, M.D., L.Ac. Citizenship: United States Home Address: 1614 W. Carmen Ave., Chicago, IL 60640 Home Phone: 773-960-8901 Business Address: East-West Integrated Medicine,
More informationSupplemental Digital Content 1. Combination antiretroviral therapy regimens utilized in each study
Supplemental Digital Content 1. Combination antiretroviral therapy regimens utilized in each study Study Almeida 2011 Auld 2011 Bassett 2012 Bastard 2012 Boulle 2008 (a) Boulle 2008 (b) Boulle 2010 Breen
More informationFrailty and age are independently associated with patterns of HIV antiretroviral use in a clinical setting. Giovanni Guaraldi
Frailty and age are independently associated with patterns of HIV antiretroviral use in a clinical setting Giovanni Guaraldi Potential conflicts of interest Research funding: Jansen, Gilead, MSD, BMS Consultancies:
More informationAntiretroviral Therapy Cohort Collaboration
Antiretroviral Therapy Cohort Collaboration http://www.bristol.ac.uk/art-cc/research/presentations/ 2015 22nd Conference on Retroviruses and Opportunistic Infections, Seattle, USA, February 2015 Margaret
More informationSupplementary information
Supplementary information Dose-response Curve Slope Sets Class-Specific Limits on Inhibitory Potential of Anti-HIV Drugs Lin Shen 1,2, Susan Peterson 1, Ahmad R. Sedaghat 1, Moira A. McMahon 1,2, Marc
More informationCURRICULUM VITAE KENNETH HUGH MAYER
CURRICULUM VITAE KENNETH HUGH MAYER PERSONAL INFORMATION Professional Address: Infectious Diseases Division The Miriam Hospital 164 Summit Avenue Providence, RI 02906 Business Telephone Number: (401) 793-4711
More informationEffects of cobicistat on tenofovir exposure and its long-term tolerability: is it time to rethink at TAF trials?
Effects of cobicistat on tenofovir exposure and its long-term tolerability: is it time to rethink at TAF trials? Sara Baldelli 1, Andrea Giacomelli 2, Davide Minisci 2, Cristina Mazzali 3, Laura Milazzo
More informationVoice: (802)
March 2009 CURRICULUM VITAE Alexandra S. Potter Ph.D. Clinical Neuroscience Research Unit Department of Psychiatry University of Vermont College of Medicine 1 South Prospect Street Burlington, VT 05401
More informationEvidence Review: Comparison between tenofovir alafenamide and tenofovir disoproxil fumarate. February For public consultation
Evidence Review: Comparison between tenofovir alafenamide and tenofovir disoproxil fumarate. February 2016 - NHS England Evidence Review: Comparison of tenofovir alafenamide and tenofovir disoproxil fumarate.
More informationCLINICAL PEARLS OF NEW HIV MEDICATIONS PHARMACIST OBJECTIVES TECHNICIAN OBJECTIVES. At the end of this presentation pharmacists will be able to:
CLINICAL PEARLS OF NEW HIV MEDICATIONS Cindy Lou Zoellner, PharmD, BCPS Added Qualifications in Infectious Diseases Senior Clinical Pharmacy Specialist in HIV Parkland Health & Hospital System Volunteer
More informationMEGAN R. PRESCOTT, LCSW, NSW-C, BCC
MEGAN R. PRESCOTT, LCSW, NSW-C, BCC megan.prescott@uchealth.org 720-848-0991 office 720-235-2400 cell Education 2012-2013 Foundational Program, Institute of Life Coach Training 2000-2002 Masters of Social
More informationClinical Commissioning Policy: Use of cobicistat as a booster in treatment of HIV infection (all ages) Reference: NHS England F03/P/b
Clinical Commissioning Policy: Use of cobicistat as a booster in treatment of HIV infection (all ages) Reference: NHS England F03/P/b NHS England INFORMATION READER BOX Directorate Medical Commissioning
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Enfuvirtide (Fuzeon) Reference Number: CP.PHAR.41 Effective Date: 10.01.18 Last Review Date: 07.13.18 Line of Business: Oregon Health Plan Revision Log See Important Reminder at the end
More informationCURRICULUM VITAE. Associate Clinical Professor of Medicine, UCSF Medical Director, Acute Care for Elders Unit, San Francisco General Hospital
CURRICULUM VITAE Name: Position: Address: Edgar Pierluissi Associate Clinical Professor of Medicine, UCSF Medical Director, Acute Care for Elders Unit, San Francisco General Hospital 1001 Potrero Avenue
More informationThe correlation between plasma concentrations of protease inhibitors, medication adherence and virological outcome in HIV-infected patients
Antiviral Therapy 9:753 761 The correlation between plasma concentrations of protease inhibitors, medication adherence and virological outcome in HIV-infected patients Julie M Yasuda 1, Chris Miller 2,3,
More informationStephen C. Jones, Ph.D. Curriculum Vitae
Stephen C. Jones, Ph.D. Curriculum Vitae Contact Information: Work Touro College of Osteopathic Medicine 230 West 125 th Street New York, NY 10027 Phone: 646-981-4500, 4609 Fax: 212-678-1784 E-mail: stephen.jones@touro.edu
More informationContraceptive Research and Development Organization
COMMONLY USED ABBREVIATIONS AND ACRONYMS IN MTN PROTOCOLS 3TC ACASI AE AIDS ALT ART ARV AST AUC BMD BV CDC cgmp CFR CI CONRAD Cmax Cmin CORE C-PMPA lamivudine audio computer-assisted self interview adverse
More informationCURRICULUM VITAE. Revised: October 18, Name: Howard Ira Levy, M.D.
CURRICULUM VITAE Revised: October 18, 2012 Name: Howard Ira Levy, M.D. Office Addresss: The Emory Orthopaedics and Spine Center 59 Executive Park South Atlanta, GA 30329 (404) 778-7138 Citizenship: U.S.A.
More informationPerspective Current Concepts in Antiretroviral Therapy Failure
International AIDS Society USA Perspective Current Concepts in Antiretroviral Therapy Failure Currently, the goal for the first and second, and possibly the third, antiretroviral regimen is the suppression
More informationAntiretroviral Dosing in Renal Impairment
Protease Inhibitors (PIs) Atazanavir Reyataz hard capsules 300 mg once daily taken with ritonavir 100 mg once daily No dosage adjustment is needed for atazanavir in renal impairment Atazanavir use in haemodialysis
More informationCURRICULUM VITAE September 2005 SUSAN E. BAKER
CURRICULUM VITAE September 2005 SUSAN E. BAKER EDUCATION Department of Speech Pathology and Audiology 25 Bachelor Hall Miami University Oxford, Ohio 45056 Phone: (513) 529-2553 Fax: (513) 529-2502 Email:
More informationCURRICULUM VITAE. Catherine J. Lesnick
CURRICULUM VITAE Name: Name of Institution: Catherine J. Lesnick Chapman University Department of Physical Therapy Crean College of Health and Behavioral Sciences Rinker Health Science Campus in Irvine
More informationDaniel J Escudero, PhD
Daniel J Escudero, PhD Research Associate T.H. Chan School of Public Health Tel: (617) 432-1899 (office); (551) 404-7592 (cell) Email: Escudero@hsph.harvard.edu 1. EDUCATION AND POSTDOCTORAL TRAINING Postdoctoral
More informationTORONTO GENERAL HOSPITAL HIV AMBULATORY CARE ROTATION
TGH - ambulatory rotation page 1 of 5 TORONTO GENERAL HOSPITAL HIV AMBULATORY CARE ROTATION SITE: Immunodeficiency Clinic, Toronto General Hospital, University Health Network Location: 13 th floor, Norman
More informationOnce-a-Day Highly Active Antiretroviral Therapy: A Systematic Review
HIV/AIDS MAJOR ARTICLE Once-a-Day Highly Active Antiretroviral Therapy: A Systematic Review Javier Ena and Francisco Pasquau HIV Unit, Department of Internal Medicine, Marina Baixa Hospital, Villajoyosa,
More informationHIV and the Central Nervous System Impact of Drug Distribution Scott L. Letendre, MD. Professor of Medicine University of California, San Diego
HIV and the Central Nervous System Impact of Drug Distribution Scott L. Letendre, MD Professor of Medicine University of California, San Diego Disclosures Grant/research support Abbvie Gilead Sciences
More informationPAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist
PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical
More informationShalini Mahajan, M.D. Director, LA Neuromuscular Center (LANMC) Attune Health, Beverly Hills, CA
Shalini Mahajan, M.D. Director, LA Neuromuscular Center (LANMC) Attune Health, Beverly Hills, CA Business Address LA Neuromuscular Center Attune Health 8750 Wilshire Blvd, Ste 350, Beverly Hills, CA 90211
More informationCrafting an ART Regimen for Initiation or Salvage: Are NRTI s Necessary?
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Crafting an ART Regimen for Initiation or Salvage: Are NRTI s Necessary? Brian R. Wood, MD Assistant Professor of Medicine, University of Washington Medical
More informationDIANA ECHEVERRY-FRANCK CURRICULUM VITAE
DIANA ECHEVERRY-FRANCK CURRICULUM VITAE PERSONAL DATA: Business Address: Charles Drew University of Medicine and Science, Clinical Trials Unit, 1731 East 120 th Street, Los Angeles, Ca 90059; (323) 357-3631
More informationIndividual Study Table Referring to the Dossier SYNOPSIS. Final Clinical Study Report for Study AI424138
Name of Sponsor/Company: Bristol-Myers Squibb Name of Finished Product: Reyataz Name of Active Ingredient: Atazanavir () Individual Study Table Referring to the Dossier (For National Authority Use Only)
More informationDRUGS IN PIPELINE. Pr JC YOMBI UCL-AIDS REFERENCE CENTRE BREACH Sept 27, 2015
DRUGS IN PIPELINE Pr JC YOMBI UCL-AIDS REFERENCE CENTRE BREACH Sept 27, 2015 N(t)RTI The Development of TAF TAF Delivers the High Potency of TDF While Minimizing Off- Target Kidney and Bone Side Effects
More informationCassondra J Marshall
Cassondra J Marshall EDUCATION University of California, Berkeley, School of Public Health, Berkeley, CA Doctor of Public Health 2015 University of California, Los Angeles, School of Public Health, Los
More informationTenofovir Alafenamide (TAF)
Frontier AIDS Education and Training Center Tenofovir Alafenamide (TAF) Brian R. Wood, MD Assistant Professor of Medicine, University of Washington Medical Director, Frontier AETC ECHO January 28, 2016
More informationCURRICULUM VITAE BRIDGETTE DO, MPH NOVEMBER 2018
PERSONAL INFORMATION CURRICULUM VITAE BRIDGETTE DO, MPH NOVEMBER 2018 Soto Street Building (SSB) 2001 Soto N. Street, 3 rd Floor, #302-10 Los Angeles, CA 90032-9045 bridgetd@usc.edu Citizenship: United
More informationMalcolm L. Margolin, M.D. OB/Gyn
CURRICULUM VITAE Malcolm L. Margolin, M.D. OB/Gyn UNDERGRADUATE EDUCATION Birmingham High School Van Nuys, CA 1957 Oregon State University Corvallis, OR 1957-1958 University of California Berkeley, CA
More informationMEHUL VIPUL MANKAD, M.D W. Main St, Suite 340 Durham, NC
5.16.2011 MEHUL VIPUL MANKAD, M.D. 2200 W. Main St, Suite 340 Durham, NC 27705 manka001@mc.duke.edu EDUCATION Fellowship Chief Residency Residency Medical School Undergraduate RUSH UNIVERSITY MEDICAL CENTER
More informationCurriculum Vitae. PERSONAL DATA Name: Harriet W. Hopf Birth Place: Madison, WI Citizenship: United States
Curriculum Vitae PERSONAL DATA Name: Harriet W. Hopf Birth Place: Madison, WI Citizenship: United States EDUCATION Years Degree Institution (Area of Study) 1978-1982 B.A. Yale University (Biology) New
More informationPhysiologically-Based Simulation of Daclatasvir Pharmacokinetics With Antiretroviral Inducers and Inhibitors of Cytochrome P450 and Drug Transporters
Physiologically-Based Simulation of Daclatasvir Pharmacokinetics With Antiretroviral Inducers and Inhibitors of Cytochrome P450 and Drug Transporters Qi Wang, Wenying Li, Ming Zheng, Timothy Eley, Frank
More informationPRELIMINARY RYAN WHITE HIV/AIDS PROGRAM CLINICAL CARE CONFERENCE AGENDA
PRELIMINARY RYAN WHITE HIV/AIDS PROGRAM CLINICAL CARE CONFERENCE AGENDA 9:00 9:15 AM Welcome and Introductions TUESDAY, DECEMBER 15, 2015 9:00 AM 5:05 PM 9:15 9:45 AM Update on the Ryan White HIV/AIDS
More informationMargarita Villagrana, PhD, MSW
Margarita Villagrana, PhD, MSW School of Social Work 5500 Campanile Drive, HH#119 San Diego, CA 92182-4119 619-594-5500 mvillagrana@sdsu.edu Education and Training 2009 Arizona State University Postdoctoral
More informationDidactic Series. Archive Genotype Resistance Testing in the Setting of Regimen Switching
Didactic Series Archive Genotype Resistance Testing in the Setting of Regimen Switching Craig Ballard, Pharm.D., AAHIVP UCSD Medical Center Owen Clinic June 11, 2015 ACCREDITATION STATEMENT: University
More informationCURRICULUM VITAE. Education: Boston University School of Public Health September December 2014 PhD. in Epidemiology, January 2015
CURRICULUM VITAE Jessica Maxwell, PT, DPT, PhD, OCS Springfield College School of Health Sciences and Rehabilitation Studies Department of Physical Therapy Education: Boston University School of Public
More informationDerek Johnson. Department of Epidemiology University of Alabama School of Public Health Birmingham, Alabama
Derek Johnson Department of Epidemiology University of Alabama School of Public Health Birmingham, Alabama E-mail: Frg1@uab.edu AREA OF INTEREST: Study Design Methodology EDUCATION Doctor of Philosophy,
More informationCurriculum Vitae. Undergraduate: Jun 1979 BA College of the Holy Cross
Curriculum Vitae Mark Paul Slovenkai MD Boston Sports and Shoulder Center 840 Winter Street Waltham, MA 02451 Tel: 781-890-2133 Mslovenkai@NEBH.org April 6, 2016 EDUCATION Undergraduate: Jun 1979 BA College
More informationUniversity of North Carolina Master of Science May 2015 Pediatric. University of North Carolina Doctor of Dental Surgery May 2012 Dentistry
Curriculum Vitae Kevin Ricker, DDS, MS EDUCATION Institution Degree Date Conferred Major University of North Carolina Residency June 2015 Pediatric Certficate Dentistry University of North Carolina Master
More informationCurriculum Vitae. Alejandro Ernesto Pino, MD
Curriculum Vitae Alejandro Ernesto Pino, MD Personal Data Place of Birth: Date of Birth: March 6, 1977 Citizenship: USA Licensure New York State License 256281 Florida State License ME 122939 NPI Number
More informationSecond-Line Therapy NORTHWEST AIDS EDUCATION AND TRAINING CENTER
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Second-Line Therapy David Spach, MD Clinical Director, Northwest AETC Professor of Medicine, Division of Infectious Diseases University of Washington Presentation
More information